General Information
Version
4
Revision date
2023-03-20
Product name
Deferoxamine Mesylate for Injection, USP (Hospira, Inc.)
Product name
Deferoxamine Mesylate for Injection, USP (Hospira, Inc.)
Identification on the label/Trade name
Deferoxamine Mesylate for Injection, USP
Product Synonyms
Desferrioxamine Mesilate; Desferrioxamine Mesylate
Chemical name
Not determined
CAS No.
138-14-7
1.2.1 Relevant identified uses
Pharmaceutical active for the treatment of iron intoxication/overload
Emergency telephone
1-800-424-9300, +1-703-527-3887
Icons in SDS
Company Information
company name
Hospira UK Limited
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
Not classified
Section 2
SECTION 2: Hazards identification
OSHA Classification of the substance or mixture
Signal word
Not classified
Hazard statements
Not classified in accordance with international standards for workplace safety.
Other hazards
Note An Occupational Exposure Value has been established for this substance ( see Section 8 ). This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
2.1 Classification of the substance or mixture
GHS - Classification: Not classified as hazardous according to Regulation (EC) 1272/2008 and/or other applicable regulations. OSHA Classification